ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2672

Characteristics of the Reproductive System in Systemic Lupus Erythematosus: A Cross-Sectional Survey with Pair-Matched Controls

Maria N Antoniol1, Cecilia Reimundes2, Cecilia Catoggio2, Analia V Longo3, Analia P Alvarez3 and Carlos Perandones4, 1Internal Medicine, CEMIC, Buenos Aires, Argentina, 2Rheumatology and Immunology, CEMIC, Buenos Aires, Argentina, 3Internal Medicine, Hospital Penna, Buenos Aires, Argentina, 4Rheumatology & Immunology, CEMIC, Buenos Aires, Argentina

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Reproductive Health

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Epidemiology, Women's Health, Cardiovascular and CNS

Session Type: Abstract Submissions (ACR)

Background/Purpose

Patients with Systemic Lupus Erythematosus (SLE) present factors associated with the reproductive system that can increase the risk of the disease, but the literature is controversial.

The reproductive system variables are influenced by multiple social, ethnic, economic and cultural factors that can function as confounding variables.  For this reason, the optimal SLE population control should be matched by age and sociodemographic features.

We compared reproductive variables of a group of women with SLE with pair-matched healthy controls.

Methods

A case-control study was performed using a cross-sectional survey to analyze variables of the reproductive system in patients with SLE. We included women over 18 years-old with SLE according to ACR criteria. Each case was matched with a healthy control belonging to her sociocultural environment and having her age ± 5 years.

The survey included multiple demographic and disease variables, as well as reproductive system features: age of menarche and menopause, number of pregnancies and fetal losses, and contraceptive methods. Paired t test and McNemar’s test or Fisher exact test were applied for continuous and categorical variables, respectively.

Results

We included 83 cases with a mean age of 39.2 ± 10.8 years (range19-66) and the mean age at SLE diagnosis was 26.9 ± 10.3 years.  Previous treatments were as follows: 91% hydroxychloroquine, 32% cyclophosphamide, 31% azathioprine, 24% mycophenolate mofetil, and 16% methotrexate.

 

 

Cases

Controls

 

Menarche (age ± SD)

12.8 ± 1.7

12.4 ± 1.4

paired t test p 0.15

Menopause (age ± SD)

43.12 ± 6.4

50.23 ± 3.7

paired t test p 0.01

Previous Oral Contraceptives (%)

42 %

50%

McNemar’s test 1.25 (p 0.26)

Pregnancies (mean ± SD)

1.7 ± 1.6

1.9 ± 1.9

paired t test p 0.34

Fetal Loss (%)

28

28

 

Fetal Loss (mean ± SD)

0.43 ± 0.8

0.43 ± 0.8

paired t test p 1.0

Children (mean ± SD)

1.25 ± 1.2

1.45 ± 1.4

paired t test p 0.24

Gestational Age (weeks) (mean ± SD)

37.8 ± 3.1

37.9 ± 3.3

t test p 0.8

Infertility Treatment (%)

6.02

9.6

Fisher exact test p 0.17

When cyclophosphamide was analized as a risk factor for early menopause there were no difference between exposed and non exposed patients

Conclusion

There were no differences in the age of menarche, previous oral contraceptives, number of pregnancies, fetal losses and children, and the need of infertility treatment between SLE patientes and pair-matched controls.

The age of menopause is significantly different but cannot be related only to cyclophosphamide.


Disclosure:

M. N. Antoniol,
None;

C. Reimundes,
None;

C. Catoggio,
None;

A. V. Longo,
None;

A. P. Alvarez,
None;

C. Perandones,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characteristics-of-the-reproductive-system-in-systemic-lupus-erythematosus-a-cross-sectional-survey-with-pair-matched-controls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology